AKT1 and cholangiocarcinoma: DHM can enhance miR-455 expression, which decreases the expression of ZEB1, p-PI3K, and p-Akt in cholangiocarcinoma cell lines RBE and TFK-1 and suppresses cell proliferation and EMT in cholangiocarcinoma [82].